Literature DB >> 16906034

High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation.

Joke I Roodnat1, Eveline A F J van Gurp, Paul G H Mulder, Teun van Gelder, Yolanda B de Rijke, Wouter W de Herder, Judith A Kal-van Gestel, Huib A P Pols, Jan N M Ijzermans, Willem Weimar.   

Abstract

BACKGROUND: Calcium (Ca), phosphate (P), and parathyroid hormone (PTH) are important variables influencing the risk for cardiovascular disease in dialysis patients. We studied the influence of long-standing Ca-P disregulation on renal transplant survival.
METHODS: Pretransplant PTH, Ca, P, total protein (TP), albumin, and alkaline phosphatase (AP) values were gathered in all 407 patients that received a renal transplant in our center between January 1, 2000 and July 1, 2004. Other variables expected to influence the risks were included. RESULTS. In the Cox proportional hazards analysis the risk for graft failure censored for death was significantly influenced by pretransplant PTH concentration (P = 0.008) and donor type (P < 0.001). The influence of PTH on the risk for patient death was not significant. The risk for acute rejection was studied but PTH level did not have a significant influence on this risk (P = 0.055). The risk for delayed graft function was not influenced by PTH level.
CONCLUSION: Serum PTH levels have an independent influence on the risk for graft failure censored for death. Efforts to improve calcium-phosphate-PTH homeostasis in patients on the waiting list for renal transplantation should be encouraged also to improve graft survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906034     DOI: 10.1097/01.tp.0000228923.75739.88

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

1.  Association of pretransplant serum phosphorus with posttransplant outcomes.

Authors:  Marcelo S Sampaio; Miklos Z Molnar; Csaba P Kovesdy; Rajnish Mehrotra; Istvan Mucsi; John J Sim; Mahesh Krishnan; Allen R Nissenson; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

2.  Association of Serum Phosphorus Concentration with Mortality and Graft Failure among Kidney Transplant Recipients.

Authors:  Hee Jung Jeon; Yong Chul Kim; Seokwoo Park; Clara Tammy Kim; Jongwon Ha; Duck Jong Han; Jieun Oh; Chun Soo Lim; In Mok Jung; Curie Ahn; Yon Su Kim; Jung Pyo Lee; Young Hoon Kim
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 8.237

Review 3.  [Waiting list management].

Authors:  U Pein; A Fritz; M Girndt
Journal:  Urologe A       Date:  2020-01       Impact factor: 0.639

Review 4.  Management of mineral and bone disorder after kidney transplantation.

Authors:  Kamyar Kalantar-Zadeh; Miklos Z Molnar; Csaba P Kovesdy; Istvan Mucsi; Suphamai Bunnapradist
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

Review 5.  Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic.

Authors:  Claudia Seikrit; Anja Mühlfeld; Hermann-Josef Groene; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2010-12-14       Impact factor: 28.314

6.  Mineral metabolism in European children living with a renal transplant: a European society for paediatric nephrology/european renal association-European dialysis and transplant association registry study.

Authors:  Marjolein Bonthuis; Marco Busutti; Karlijn J van Stralen; Kitty J Jager; Sergey Baiko; Sevcan Bakkaloğlu; Nina Battelino; Maria Gaydarova; Bruno Gianoglio; Paloma Parvex; Clara Gomes; James G Heaf; Ludmila Podracka; Dafina Kuzmanovska; Maria S Molchanova; Tatiana E Pankratenko; Fotios Papachristou; György Reusz; Maria José Sanahuja; Rukshana Shroff; Jaap W Groothoff; Franz Schaefer; Enrico Verrina
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-20       Impact factor: 8.237

7.  Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.

Authors:  Mariël L te Winkel; Robert D van Beek; Sabine M P F de Muinck Keizer-Schrama; André G Uitterlinden; Wim C J Hop; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

8.  A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.

Authors:  Josep M Cruzado; Pablo Moreno; José V Torregrosa; Omar Taco; Richard Mast; Carmen Gómez-Vaquero; Carolina Polo; Ignacio Revuelta; José Francos; Joan Torras; Arantxa García-Barrasa; Oriol Bestard; Josep M Grinyó
Journal:  J Am Soc Nephrol       Date:  2015-12-08       Impact factor: 10.121

9.  Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes.

Authors:  Miklos Z Molnar; Csaba P Kovesdy; Istvan Mucsi; Isidro B Salusky; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-06       Impact factor: 8.237

10.  Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients.

Authors:  Whitney Sutton; Xiaomeng Chen; Palak Patel; Shkala Karzai; Jason D Prescott; Dorry L Segev; Mara McAdams-DeMarco; Aarti Mathur
Journal:  Surgery       Date:  2021-07-12       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.